Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Carcinoma%2C+Non-Small-Cell+Lung%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
/vufind/Search/Results?lookfor=%22Carcinoma%2C+Non-Small-Cell+Lung%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
Search /vufind/Search2/Results?lookfor=%22Carcinoma%2C+Non-Small-Cell+Lung%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
PubPharm (1.309)
1
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) : A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (B-FAST: Blood-First Assay Screening Trial)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment : Open-Label, Phase 1/2 Study Evaluating the Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, and the Tolerability and Antitumor Activity of Selinexor Combination Treatment (SPRINT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of SGN-B6A in Advanced Solid Tumors : A Phase 1 Study of SGN-B6A in Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer : Nano-SMART: An Adaptive Phase I-II Trial of AGuIX Gadolinium-based Nanoparticles With Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Centrally Located Lung Tumors and Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) : A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer : A Randomized, Controlled, Open Label, Phase III Study Evaluating the Efficacy and Safety of JDQ443 Versus Docetaxel in Previously Treated Subjects With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) : A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer : A Phase 2 Trial of SX-682 and Pembrolizumab in Patients With Treatment Naive Stage IV or Recurrent Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers : ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer : Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[131]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
1.309
Aufsätze
1.309
E-Artikel
1.309
E-Ressourcen
Zeitschriftentitel
1.275
ClinicalTrials.gov
34
WHO International Clinical Trials Registry Plat...
Thema
1.309
610
Recruitment Status: Recruiting
1.269
Carcinoma, Non-Small-Cell Lung
1.090
Study Type: Interventional
834
Lung Neoplasms
386
Phase: Phase 2
215
Study Type: Observational
187
Phase: Phase 1
159
Phase: Phase 3
147
Phase: Phase 1, Phase 2
137
Carcinoma
68
Neoplasms
52
Colorectal Neoplasms
43
Medical Condition: Non-small Cell Lung Cancer
38
Medical Condition: Non Small Cell Lung Cancer
38
Melanoma
35
Neoplasm Metastasis
33
Carcinoma, Squamous Cell
33
Squamous Cell Carcinoma of Head and Neck
31
Breast Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.247
2020-
62
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.307
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...